---
title: Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics
description: "Watch this webinar to learn about the latest technologies purpose-built to meet the challenges of the biopharmaceutical industry such as:\n\nA multi-capillary electrophoresis system that enables researchers to run multiple samples significantly faster than traditional methods, allowing for high-throughput analysis of protein purity and stability, as well as genome integrity and AAV purity.\n\nA novel LC-MS/MS QTOF instrument, as well as the software applications and advanced data processing capabilities employed to provide complete sample characterization, including impurities identification."
image: https://go.technologynetworks.com/hubfs/Technology%20Networks/TN%20Editorial%20Calendar/Article/SCIEX%20-%20Article%20Sponsorship/December%202021/Sciex%20webinar%20social.png
---

![TN_Stacked](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked.svg "TN_Stacked")

![Sciex Logo White](https://go.technologynetworks.com/hs-fs/hubfs/Sciex%20Logo%20White.png?width=200&height=97&name=Sciex%20Logo%20White.png "Sciex Logo White")

Webinar

# Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics

WATCH ON-DEMAND

Biopharmaceutical companies are transitioning from the development of standard monoclonal antibody therapies to more intricate antibody structures and new genetic medicines. Not only are these molecules more complex, but scientists are also under tremendous pressure to understand molecular liabilities sooner and close the developability gap in a much shorter time frame. As such, analytical evaluation of these sophisticated samples is getting more complex, more numerous and results are required in less time. As a result, investigators are in dire need of technologies that are fast and robust enough to keep up with the development pace of next-generation biotherapeutics.

**Watch this webinar to learn about the latest technologies purpose-built to meet the challenges of the biopharmaceutical industry such as:**

- A multi-capillary electrophoresis system that enables researchers to run multiple samples significantly faster than traditional methods, allowing for high-throughput analysis of protein purity and stability, as well as genome integrity and AAV purity.
- A novel LC-MS/MS QTOF instrument, as well as the software applications and advanced data processing capabilities employed to provide complete sample characterization, including impurities identification.

**Speaker Information:**

![Sahana mollah](https://go.technologynetworks.com/hs-fs/hubfs/Sahana%20mollah.png?width=86&height=81&name=Sahana%20mollah.png)

Sahana Mollah  
Senior Manager   
CE/Biopharma Applications

![Andrew Mahan](https://go.technologynetworks.com/hs-fs/hubfs/Andrew%20Mahan.png?width=102&height=96&name=Andrew%20Mahan.png)

**Andrew Mahan**  
Principal Scientist/MS Group Leader  
Cell & Developability Sciences Janssen Pharmaceutical Companies of Johnson & Johnson

![Zoe Zhang](https://go.technologynetworks.com/hs-fs/hubfs/Zoe%20Zhang.png?width=86&height=81&name=Zoe%20Zhang.png)

Zoe Zhang, PhD  
Manager   
Biopharma Sciex

Watch this webinar to learn about the latest technologies purpose-built to meet the challenges of the biopharmaceutical industry such as:

- A multi-capillary electrophoresis system that enables researchers to run multiple samples significantly faster than traditional methods, allowing for high-throughput analysis of protein purity and stability, as well as genome integrity and AAV purity.
- A novel LC-MS/MS QTOF instrument, as well as the software applications and advanced data processing capabilities employed to provide complete sample characterization, including impurities identification.

Watch for FREE Now!

 

 

![TN_Stacked](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked.svg "TN_Stacked")

Technology Networks Limited   
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK   
Email: privacy@technologynetworks.com   
© 2022 Technology Networks. All rights reserved

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)